Skip to main content
. 2021 Oct 22;7(43):eabj8016. doi: 10.1126/sciadv.abj8016

Table 1. Number of human studies and sample size by participant sex overall and for each DRI report section.

Characteristics Section in the DRI reports
Indicator Life stages Upper level Total
Number of studies N = 233 N = 336 N = 102 N = 671
Included women 157 (67.4%) 285 (84.8%) 78 (76.4%) 520 (77.5%)
Included pregnant or lactating women* 12 (5.2%) 98 (29.2%) 7 (6.9%) 117 (17.4%)
Men only 58 (24.9%) 38 (11.3%) 15 (14.7%) 111 (16.5%)
Sex unspecified 18 (7.7%) 13 (3.9%) 9 (8.8%) 40 (6.0%)
Sample size among 640 studies reporting
sample size by sex
n = 674,522 n = 53,646 n = 185,997 n = 914,137
Sample size of all women, n (%) 190,818 (28.3%) 30,220 (56.3%) 42,884 (23.1%) 263,922 (28.9%)
Pregnant or lactating women, n (%) 482 (0.1%) 18,144 (33.8%) 23,521 (12.6%) 42,147 (4.6%)
Sample size of all men, n (%) 483,704 (71.7%) 23,398 (43.6%) 143,113 (76.9%) 650,215 (71.1%)
Sample size of men in studies that only
included men, n (%)§
404,362 (59.9%) 1,015 (1.9%) 284 (0.2%) 405,629 (44.4%)

*Studies that included pregnant or lactating women are nested within studies that included women; we combined pregnant and lactating women into the same category.

†Sample size with unspecified sex: n = 46,086, n = 782, and n = 4393 in the indicator, life stages, and upper level sections, respectively (total = 51,261).

‡Not all studies reported sample size for women or pregnant women, even when they were included.

§Subset of the “men” category.